Zhe Cheng
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 6
-
- RNA modifications and cancer 6
- Inflammasome and immune disorders 3
- Circular RNAs in diseases 3
-
- interferon and immune responses 2
- IL-33, ST2, and ILC Pathways 2
-
- Cancer Cells and Metastasis 2
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Zhe Cheng
24 papers receiving 738 citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Cancer Research 365
- Molecular Biology 445
- Immunology 111
- Periodontics 14
- Pulmonary and Respiratory Medicine 75
Countries citing papers authored by Zhe Cheng
This map shows the geographic impact of Zhe Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhe Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhe Cheng more than expected).
Fields of papers citing papers by Zhe Cheng
This network shows the impact of papers produced by Zhe Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhe Cheng. The network helps show where Zhe Cheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhe Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Photooxidation triggered ultralong afterglow in carbon nanodotsbreakdown → | 2024 | 73 |
| 2 | 2024 | 2 | |
| 3 | 2023 | 17 | |
| 4 | 2022 | 7 | |
| 5 | 2021 | 10 | |
| 6 | 2021 | 8 | |
| 7 | 2021 | 4 | |
| 8 | 2020 | 48 | |
| 9 | 2020 | 11 | |
| 10 | 2019 | 15 | |
| 11 | 2018 | 61 | |
| 12 | 2018 | 26 | |
| 13 | 2018 | 77 | |
| 14 | 2018 | 89 | |
| 15 | 2016 | 10 | |
| 16 | 2016 | 3 | |
| 17 | 2015 | 75 | |
| 18 | 2015 | 68 | |
| 19 | [Effects of Akt2-siRNA on chemotherapeutic sensitivity and drug resistance in human lung cancer cells]. | 2011 | 1 |
| 20 | [Changes of HMGB1 and RAGE in induced sputum from patients with bronchial asthma]. | 2011 | 3 |
About Zhe Cheng
Zhe Cheng is a scholar working on Cancer Research, Molecular Biology and Immunology, having authored 24 papers that have together received 744 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (6 papers), RNA modifications and cancer (6 papers), Inflammasome and immune disorders (3 papers), Circular RNAs in diseases (3 papers), interferon and immune responses (2 papers), IL-33, ST2, and ILC Pathways (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (365 citations), Molecular Biology (445 citations) and Immunology (111 citations). Zhe Cheng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Lingling Dai, Tianci Jiang, Xi Wang, Xiaogang Jing, Liuqun Jia, Lin An, Xuetao Li, Youxin Zhou, Yulun Huang and Yong Han.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.